Intract Pharma Ltd is a licensing and product development company offering advanced drug delivery technologies and unique gastrointestinal (GI) models for product innovation. As a spin-out of University College London, our company is centered around more than 20 years of research from the laboratory of Prof. Abdul Basit. We specialize in oral drug delivery and offer a range of proprietary technologies to help overcome formulation challenges and enhance product performance. Complementary to these, we have developed unique GI models as strategic tools to provide expert analysis of formulation behavior under physiologically appropriate conditions. Our drug delivery technologies have been licensed across various therapeutic indications, with products at different stages of clinical development, including Phase III studies. In addition, our in-house research and development pipeline includes the preclinical evaluation of a range of products with strong scientific and commercial promise.
Using our specialist knowledge and experience, we can help you establish the pathway from early stage pre-clinical development through to clinical and commercial manufacture.
Intract Pharma has not received any reviews.
Intract Pharma has not received any endorsements.